Form 4 Tracker
ACADIA PHARMACEUTICALS INC
ACAD

26 insider filings · Latest: Jun 26, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 26, 2026Jun 29 10:00 PMJames KiharaPRINCIPAL ACCOUNTING OFFICER
Sale
11,421$26.08$297.9K13,088(D)

View →

Jun 26, 2026Jun 26 7:09 PMKihara James
Proposed Sale
11,421$26.00$297.0K

View →

May 26, 2026May 27 10:00 PMJames KiharaPRINCIPAL ACCOUNTING OFFICER
Sale
5,401$21.18$114.4K24,509(D)

View →

May 26, 2026May 26 8:02 PMJAMES K KIHARA
Proposed Sale
5,401$21.18$114.4K

View →

May 4, 2026May 5 10:00 PMJames KiharaPRINCIPAL ACCOUNTING OFFICER
Sale
1,332$21.79$29.0K29,129(D)

View →

May 4, 2026May 5 10:00 PMMark C. SchneyerEVP, CHIEF FINANCIAL OFFICER
Sale
3,506$21.79$76.4K66,145(D)

View →

Apr 7, 2026Apr 7 11:57 PMMark C. SchneyerEVP, CHIEF FINANCIAL OFFICER
Sale
2,709$22.20$60.1K62,836(D)

View →

Apr 7, 2026Apr 7 11:55 PMJames KiharaPRINCIPAL ACCOUNTING OFFICER
Sale
1,030$22.20$22.9K27,865(D)

View →

Mar 25, 2026Mar 27 12:00 AMAdams Catherine OwenDirector, Chief Executive Officer
Sale
11,641$21.47$249.9K14,803(D)

View →

Mar 25, 2026Mar 27 12:00 AMElizabeth H.Z. ThompsonEVP, Head of Research & Dev
Sale
3,435$21.47$73.7K3,280(D)

View →

Mar 25, 2026Mar 27 12:00 AMJennifer J RhodesEVP, CHIEF LEGAL OFFICER, SEC
Sale
3,844$21.47$82.5K11,280(D)

View →

Mar 26, 2026Mar 27 12:00 AMJames KiharaPRINCIPAL ACCOUNTING OFFICER
Sale
1,109$21.65$24.0K26,885(D)

View →

Mar 25, 2026Mar 27 12:00 AMJames KiharaPRINCIPAL ACCOUNTING OFFICER
Sale
833$21.47$17.9K25,852(D)

View →

Mar 26, 2026Mar 27 12:00 AMMark C. SchneyerEVP, CHIEF FINANCIAL OFFICER
Sale
3,208$21.65$69.5K60,269(D)

View →

Mar 25, 2026Mar 27 12:00 AMMark C. SchneyerEVP, CHIEF FINANCIAL OFFICER
Sale
4,177$21.47$89.7K57,299(D)

View →

Feb 9, 2026Feb 10 11:00 PMJennifer J RhodesEVP, CHIEF LEGAL OFFICER, SEC
Sale
6,950$23.38$162.5K7,609(D)

View →

Nov 10, 2025Nov 10 10:59 PMJames M Daly
Proposed Sale
30,000$22.37$671.0K

View →

Aug 18, 2025Aug 18 8:31 PMSchneyer Mark C.
Proposed Sale
22,000$25.33$557.3K

View →

Jun 4, 2025Jun 4 8:35 PMLAURA BREGE
Proposed Sale
14,446$21.78$314.6K

View →

May 16, 2025May 16 9:10 PMSchneyer Mark C.
Proposed Sale
2,000$17.60$35.2K

View →

Page 1 of 2

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 25, 2026Mar 27 12:00 AMJames KiharaPRINCIPAL ACCOUNTING OFFICER
Option Exercise
2,1424,284(D)

View →

Mar 24, 2026Mar 27 12:00 AMJames KiharaPRINCIPAL ACCOUNTING OFFICER
Option Exercise
1,6274,883(D)

View →

Mar 25, 2026Mar 27 12:00 AMMark C. SchneyerEVP, CHIEF FINANCIAL OFFICER
Option Exercise
6,17812,358(D)

View →

Mar 24, 2026Mar 27 12:00 AMMark C. SchneyerEVP, CHIEF FINANCIAL OFFICER
Option Exercise
8,13824,414(D)

View →

Mar 3, 2026Mar 20 10:01 PMJonathan PooleDirector
Grant/Award
17,275$22.502,010(D)

View →

Mar 6, 2026Mar 10 10:00 PMJames KiharaPRINCIPAL ACCOUNTING OFFICER
Grant/Award
28,098$22.166,332(D)

View →

Mar 6, 2026Mar 10 10:00 PMJennifer J RhodesEVP, CHIEF LEGAL OFFICER, SEC
Grant/Award
117,073$22.1626,382(D)

View →

Mar 6, 2026Mar 10 10:00 PMMark C. SchneyerEVP, CHIEF FINANCIAL OFFICER
Grant/Award
117,073$22.1626,382(D)

View →

Mar 6, 2026Mar 10 10:00 PMThomas GarnerEVP, Chief Commercial Officer
Grant/Award
126,440$22.1628,493(D)

View →

Mar 6, 2026Mar 10 10:00 PMElizabeth H.Z. ThompsonEVP, Head of Research & Dev
Grant/Award
131,122$22.1629,548(D)

View →

Mar 6, 2026Mar 10 10:00 PMAdams Catherine OwenDirector, Chief Executive Officer
Grant/Award
339,514$22.1676,509(D)

View →

Feb 6, 2026Feb 10 11:00 PMJennifer J RhodesEVP, CHIEF LEGAL OFFICER, SEC
Option Exercise
12,94412,945(D)

View →

← Previous

Page 2 of 2